These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
799 related items for PubMed ID: 14613961
1. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents. Lu T, Drlica K. J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961 [Abstract] [Full Text] [Related]
2. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Bhusal Y, Shiohira CM, Yamane N. Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578 [Abstract] [Full Text] [Related]
3. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Paramasivan CN, Sulochana S, Kubendiran G, Venkatesan P, Mitchison DA. Antimicrob Agents Chemother; 2005 Feb; 49(2):627-31. PubMed ID: 15673743 [Abstract] [Full Text] [Related]
4. [Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis]. Jia PP, Zhao LL, Li XY, Zhang Q, Liu ZL, Wang X, Yu LY, Zhao LX, Cen S. Yao Xue Xue Bao; 2011 Apr; 46(4):377-82. PubMed ID: 21751489 [Abstract] [Full Text] [Related]
5. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid. Steinbrück PW. Acta Tuberc Pneumol Belg; 1969 Apr; 60(3):413-6. PubMed ID: 4984421 [No Abstract] [Full Text] [Related]
6. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods]. Skriagina EM, Zalutskaia OM, Roth A, Mauch H, Nikolenko EN. Probl Tuberk; 2001 Apr; (5):43-5. PubMed ID: 11588962 [Abstract] [Full Text] [Related]
7. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry. Akselband Y, Cabral C, Shapiro DS, McGrath P. J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276 [Abstract] [Full Text] [Related]
8. [Sensitivity of m. kansasii strains to various antibiotics and chemotherapeutics in vitro and in vivo (author's transl)]. Burjanová B, Dornetzhuber V. Z Erkr Atmungsorgane; 1975 Jan; 142(1):68-77. PubMed ID: 58490 [Abstract] [Full Text] [Related]
9. A whole blood bactericidal assay for tuberculosis. Wallis RS, Palaci M, Vinhas S, Hise AG, Ribeiro FC, Landen K, Cheon SH, Song HY, Phillips M, Dietze R, Ellner JJ. J Infect Dis; 2001 Apr 15; 183(8):1300-3. PubMed ID: 11262217 [Abstract] [Full Text] [Related]
10. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein. Hartkoorn RC, Chandler B, Owen A, Ward SA, Bertel Squire S, Back DJ, Khoo SH. Tuberculosis (Edinb); 2007 May 15; 87(3):248-55. PubMed ID: 17258938 [Abstract] [Full Text] [Related]
11. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order]. Makarevich NM, Rudoĭ NM. Antibiotiki; 1971 Feb 15; 16(2):149-52. PubMed ID: 4326726 [No Abstract] [Full Text] [Related]
12. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Rastogi N, Labrousse V, Goh KS. Curr Microbiol; 1996 Sep 15; 33(3):167-75. PubMed ID: 8672093 [Abstract] [Full Text] [Related]
13. Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model. Cremades R, Rodríguez JC, García-Pachón E, Galiana A, Ruiz-García M, López P, Royo G. J Antimicrob Chemother; 2011 Oct 15; 66(10):2281-3. PubMed ID: 21733966 [Abstract] [Full Text] [Related]
14. Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs. Tomioka H, Sato K, Shimizu T, Sano C. J Infect; 2002 Apr 15; 44(3):160-5. PubMed ID: 12099742 [Abstract] [Full Text] [Related]
15. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro]. Janowiec M, Zwolska-Kwiek Z. Pneumonol Pol; 1983 Dec 15; 51(12):607-12. PubMed ID: 6199778 [No Abstract] [Full Text] [Related]
16. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. Schön T, Juréen P, Giske CG, Chryssanthou E, Sturegård E, Werngren J, Kahlmeter G, Hoffner SE, Angeby KA. J Antimicrob Chemother; 2009 Oct 15; 64(4):786-93. PubMed ID: 19633001 [Abstract] [Full Text] [Related]
17. [Antitubercular effect of capreomycin in vitro]. Janowiec M. Gruzlica; 1969 Jul 15; 37(7):629-35. PubMed ID: 4981783 [No Abstract] [Full Text] [Related]
18. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. Wang JY, Lee LN, Lai HC, Wang SK, Jan IS, Yu CJ, Hsueh PR, Yang PC. J Antimicrob Chemother; 2007 May 15; 59(5):860-5. PubMed ID: 17412727 [Abstract] [Full Text] [Related]
19. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada. Bozeman L, Burman W, Metchock B, Welch L, Weiner M, Tuberculosis Trials Consortium. Clin Infect Dis; 2005 Feb 01; 40(3):386-91. PubMed ID: 15668861 [Abstract] [Full Text] [Related]
20. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo]. Janowiec M, Andrzejczyk Z, Marczewska J. Pneumonol Pol; 1989 May 01; 57(5):300-7. PubMed ID: 2633149 [Abstract] [Full Text] [Related] Page: [Next] [New Search]